| Trial ID: | L1212 |
| Source ID: | NCT03063190
|
| Associated Drug: |
Vitamin D
|
| Title: |
Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
|
| Acronym: |
RLS
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Restless Leg Disorder|Renal Disease Bone|Renal Disease, End Stage|Hyperparathyroidism, Secondary|Adynamic Bone Disease|Vitamin D Deficiency
|
| Interventions: |
DRUG: Vitamin D|DRUG: Placebo Oral Tablet
|
| Outcome Measures: |
Primary: Improvement RLS severity, Reduction of the disease's symptoms, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Sao Paulo General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2022-03-31
|
| Completion Date: |
2023-03
|
| Results First Posted: |
|
| Last Update Posted: |
2021-09-30
|
| Locations: |
Hospital das Clinicas, Sao Paulo, SP, 05403-000, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT03063190
|
